Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jan;75(1):35-40.

Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes

Affiliations

Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes

R Misra et al. Clin Exp Immunol. 1989 Jan.

Abstract

To elucidate the mechanisms of autoantibody induction in infectious mononucleosis (IM), we have studied sera from 35 patients with IM with enzyme-linked immunosorbent assays using purified antigens. In the IM group 37% had IgM antibodies to cardiolipin above the normal range (mean plus 2 standard deviations of control sera). Significantly elevated frequencies of antibodies to actin (26%) and cytoskeletal antigens (97% versus 29% in normal sera) were also found, but levels of IgM rheumatoid factors, IgM antibodies to single-stranded DNA and antibodies to ribonucleoproteins (nRNP/Sm, Sm and La) were normal. Affinity purified anti-cardiolipin antibodies reacted with the cell membrane of transformed lymphocytes but not with resting cells, suggesting that cell activation was required for the expression of antigenic epitopes. Our data suggest that the autoantibody response in IM is restricted to two classes of autoantigens: cytoskeletal and cell membrane antigens. The appearance of antigenic epitopes on EBV-transformed lymphocytes could be a mechanism for the generation of anti-cardiolipin antibodies in infectious mononucleosis. Similar mechanisms could operate in autoimmune rheumatic disease.

PubMed Disclaimer

References

    1. Lancet. 1968 Mar 16;1(7542):561-3 - PubMed
    1. Br Med J. 1963 Mar 9;1(5331):656-8 - PubMed
    1. Lancet. 1972 Feb 19;1(7747):399-403 - PubMed
    1. Int Arch Allergy Appl Immunol. 1973;45(4):631-7 - PubMed
    1. J Exp Med. 1973 Dec 1;138(6):1365-78 - PubMed

Publication types

LinkOut - more resources